Additionally, levels of gut microbiota metabolic byproducts, such as short-chain fatty acids, are found to be lower in PCOS patients, which can adversely affect insulin sensitivity and further exacerbate the metabolic issues associated with PCOS (28). This evidence concerns the gene INS and polycystic ovary syndrome.